Here are some more key details from the report:
- Notable developments in the global ENT device market include Stryker’s acquisition of Entellus Medical, Johnson & Johnson’s Acclarent in collaboration with Bioscience Webster and Olympus Corporation’s launch of a rhino-laryngo videoscope, all in 2018.
- Other developments include Intersect ENT’s FDA approval of a sinus implant in 2017 and Carl Zeiss Meditech AG’s launch of devices to improve workflow for ENT procedures in 2018.
- The rise in ENT disorders, especially among children, is expected to be a key driver in the market for devices. This may also lead to more reimbursement support to patients.
- More people are preferring minimally invasive surgeries, which is expected to drive developments in medical technologies.
Read the full release and access the reports here.
More articles on surgery centers:
10 recent ASC leadership moves
Virginia ASC takes infection prevention to new level — 3 insights
Surgery Partners goes all-in on cardiology — 5 quotes on its quarterly performance
